Arthur R. Thompson, MD, PhD, Director of the Hemophilia Care Program and Hemostasis Laboratories at Puget Sound Blood Center (PSBC), recently announced that he will retire on September 30, 2008. During his 35-year tenure as head of PSBC in Seattle, Thompson was noted for several significant research accomplishments.
Thompson and Richard B. Counts, MD, PSBC’s current President and CEO, jointly established the Hemophilia Care Program in 1973. The center cares for bleeding disorder patients from Idaho, Washington and western Montana. Thompson’s research studies on the mutations that cause genetic defects in hemophilia A and B, have allowed for a much better understanding of the structure and function of factor proteins VIII and IX. He also researched hemophilia gene transfer and inhibitors. Thompson participated in the first gene transplant studies, helping suggest the feasibility of gene transfer as a potential cure for hemophilia. His recent focus has been on understanding the body’s immune response to infused FVIII.
Thompson has written more than 100 scientific papers, published in such journals as Blood, Neurogenetics and the Journal of Thrombosis and Haemostasis.
Thompson received his undergraduate degree from Amherst College in Massachusetts, and his MD and PhD in Biochemistry from UW. He interned at New York Hospital, Cornell Medical Center, in Manhattan before serving two years with the U.S. Army. He has been a professor of medicine at the University of Washington’s (UW) Division of Hematology since 1984. Thompson is a current member of the National Hemophilia Foundation’s Medical and Scientific Advisory Council (MASAC).
“Dr. Arthur Thompson has made incredible contributions to the field of hemophilia treatment and to the growth of Puget Sound Blood Center,” said Counts. “The Blood Center’s Hemophilia Program now supports over one thousand individuals with congenital bleeding disorders and their families throughout Washington state and is considered our nation’s leading hemophilia care program, largely due to Dr. Thompson and his research. We wish him well in his retirement and thank him for the service he has provided to the Blood Center and the community.”
Source: Eastside Business Journal, July 12, 2008